GlassScriptPhysician profile
Amy M Neal
NPI 1518929215
$2,986.91
in general payments reported to CMS, 2019-2025
38 companies · $1,018 in 2025
The $1,018 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.64 · 2020: $21.75 · 2021: $208 · 2022: $336 · 2023: $518 · 2024: $851 · 2025: $1,018.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,386.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $742.24 | 2021-2025 | |
| Abbott Laboratories | $312.26 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2, Thoratec Heartmate 3 Lvas Implant Kit |
| Glaxosmithkline, LLC. | $176.67 | 2021-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $157.55 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $155.93 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $133.81 | 2021-2025 | Jardiance, Tradjenta |
| Pfizer INC. | $118.81 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $84.33 | 2022-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Otsuka America Pharmaceutical, INC. | $81.77 | 2024-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $81.09 | 2023-2025 | |
| Edwards Lifesciences Corporation | $80.28 | 2025 | Sapien 3 Ultra Resilia |
| Exact Sciences Corporation | $62.13 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $61.99 | 2024-2025 | Airsupra, Farxiga |
| Dexcom, INC. | $61.73 | 2021-2025 | Dexcom G6 Transmitter |
| Daiichi Sankyo INC. | $53.34 | 2024-2025 | Injectafer |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Neal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.